---
title: "Shenzhen Salubris submits listing application to Hong Kong stock exchange"
description: "Shenzhen Salubris submits listing application to Hong Kong stock exchange"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/275832059.md"
published_at: "2026-02-13T01:16:05.000Z"
---

# Shenzhen Salubris submits listing application to Hong Kong stock exchange

### Related Stocks

- [44080.HK - SIHUAN PHARM PREF OFFER](https://longbridge.com/en/quote/44080.HK.md)
- [513700.CN - Penghua CSI HK Connect Health Care Composite ETF](https://longbridge.com/en/quote/513700.CN.md)
- [513120.CN - GF CSI HK Innovative Drugs Industry ETF(QDII)](https://longbridge.com/en/quote/513120.CN.md)
- [159316.CN - E Fund Hang Seng SCHK Innovative Drug ETF](https://longbridge.com/en/quote/159316.CN.md)
- [520880.CN - Hwabao WP Hang Seng SCHK Innovative Drug Select ETF](https://longbridge.com/en/quote/520880.CN.md)
- [25298.HK - 博瑞生物医药(苏州)股份有限公司](https://longbridge.com/en/quote/25298.HK.md)
- [159892.CN - ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)](https://longbridge.com/en/quote/159892.CN.md)
- [159570.CN - China Universal CNI HK Connect Innovative Drugs Industry ETF](https://longbridge.com/en/quote/159570.CN.md)
- [520500.CN - Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)](https://longbridge.com/en/quote/520500.CN.md)
- [520690.CN - Bosera Hang Seng SCHK Innovative Drug Select ETF](https://longbridge.com/en/quote/520690.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/en/news/276051793.md) |
| Sino Biopharm Wins China Nod for New Lung Cancer Use of PD-L1 Drug | Sino Biopharmaceutical has received Chinese regulatory approval for its PD-L1 inhibitor, benmelstobart, for use as maint | [Link](https://longbridge.com/en/news/276016059.md) |
| Ascletis Pharma Raises HK$844 Million in Private Share Placement | Ascletis Pharma Inc. has successfully raised HK$844 million through a private placement of 69,256,000 new shares at HK$1 | [Link](https://longbridge.com/en/news/275434090.md) |
| Beijing Tong Ren Tang Chinese Medicine Co. Ltd. Held Extraordinary General Meeting | Beijing Tong Ren Tang Chinese Medicine Co. Ltd. held an extraordinary general meeting on February 11, 2026, where all pr | [Link](https://longbridge.com/en/news/275583242.md) |
| Abbisko Cayman Board to Approve Audited Annual Results and Consider Final Dividend | Abbisko Cayman Ltd. will hold a board meeting on March 2, 2026, to approve its audited annual results for the year endin | [Link](https://longbridge.com/en/news/275573355.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.